GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » EV-to-EBIT

Alpha Tau Medical (Alpha Tau Medical) EV-to-EBIT : -4.17 (As of May. 22, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Alpha Tau Medical's Enterprise Value is $120.30 Mil. Alpha Tau Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-28.85 Mil. Therefore, Alpha Tau Medical's EV-to-EBIT for today is -4.17.

The historical rank and industry rank for Alpha Tau Medical's EV-to-EBIT or its related term are showing as below:

DRTS' s EV-to-EBIT Range Over the Past 10 Years
Min: -56.66   Med: 0   Max: 0
Current: -4.14

DRTS's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Biotechnology industry
Industry Median: 10.09 vs DRTS: -4.14

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Alpha Tau Medical's Enterprise Value for the quarter that ended in Mar. 2024 was $140.92 Mil. Alpha Tau Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-28.85 Mil. Alpha Tau Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -20.47%.


Alpha Tau Medical EV-to-EBIT Historical Data

The historical data trend for Alpha Tau Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Tau Medical EV-to-EBIT Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - -3.57 -4.86

Alpha Tau Medical Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.14 -6.40 -5.16 -4.86 -4.89

Competitive Comparison of Alpha Tau Medical's EV-to-EBIT

For the Biotechnology subindustry, Alpha Tau Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Tau Medical's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's EV-to-EBIT falls into.



Alpha Tau Medical EV-to-EBIT Calculation

Alpha Tau Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=120.295/-28.846
=-4.17

Alpha Tau Medical's current Enterprise Value is $120.30 Mil.
Alpha Tau Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-28.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Tau Medical  (NAS:DRTS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Alpha Tau Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-28.846/140.91727
=-20.47 %

Alpha Tau Medical's Enterprise Value for the quarter that ended in Mar. 2024 was $140.92 Mil.
Alpha Tau Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-28.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Tau Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Alpha Tau Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpha Tau Medical (Alpha Tau Medical) Business Description

Traded in Other Exchanges
N/A
Address
5 Kiryat Hamada Street, Building B3, 4th Floor, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.